Cinctive Capital Management LP Takeda Pharmaceutical CO LTD Transaction History

Cinctive Capital Management LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$16.3 - $17.26 $5.05 Million - $5.34 Million	-309,541 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$16.55 - $18.64 $899,525 - $1.01 Million	54,352 Added 21.3%	309,541 $5.21 Million
Q1 2021 May 17, 2021	SELL	$16.71 - $19.9 $1.23 Million - $1.47 Million	-73,856 Reduced 22.45%	255,189 $4.66 Million
Q4 2020 Feb 16, 2021	SELL	$15.39 - $18.97 $37,536 - $46,267	-2,439 Reduced 0.74%	329,045 $5.99 Million
Q3 2020 Nov 16, 2020	BUY	$17.1 - $19.19 $1.09 Million - $1.22 Million	63,800 Added 23.83%	331,484 $5.91 Million
Q2 2020 Aug 14, 2020	SELL	$14.59 - $19.5 $12,051 - $16,107	-826 Reduced 0.31%	267,684 $4.8 Million
Q1 2020 May 15, 2020	SELL	$13.02 - $20.31 $1.89 Million - $2.94 Million	-144,890 Reduced 35.05%	268,510 $4.08 Million
Q4 2019 Feb 14, 2020	BUY	$16.88 - $20.83 $6.98 Million - $8.61 Million	413,400 New	413,400 $8.16 Million

336

73.8M

1.96M

165K

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $42.3B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

Get notified when there are updates to the investment portfolio of Cinctive Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Cinctive Capital Management LP with notifications on news.